ArticleEuropean archives of psychiatry and clinical neuroscience2025
Interactive effect of BDNF rs10835210 polymorphism and childhood maltreatment on cognitive functioning in Chinese male patients with methamphetamine use disorder.
Article in European archives of psychiatry and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundPatients with methamphetamine use disorder (MUD) are known to experience cognitive dysfunction. Our previous study was the first to demonstrate the negative impact of childhood maltreatment (CM) on cognitive function in MUD patients. Extensive research has highlighted the crucial role of brain-derived neurotrophic factor (BDNF) gene polymorphisms in cognitive function. However, whether genetic variations in BDNF interact with environmental factors such as CM to influence cognition remains unclear. Therefore, this study aimed to investigate the potential interaction between BDNF gene polymorphism and CM in affecting cognitive function among MUD patients.
methodsWe recruited 558 MUD patients and 459 healthy controls, assessed cognitive function using the Repeated Battery for the Assessment of Neuropsychological Status (RBANS) and CM using the Chinese version of the Childhood Trauma Questionnaire-Short Form (CTQ-SF) in all participants, and genotyped all patients and 158 healthy controls for the BDNF rs10835210 polymorphism.
resultsCM negatively affected cognitive performance in both MUD patients and healthy controls, especially in visuospatial/constructional abilities (HC: FDR p < 0.001), attention (HC: FDR p = 0.008; MUD: FDR p < 0.001), and RBANS total score (HC: FDR p < 0.001; MUD: FDR p = 0.006). Furthermore, a significant interaction between CM and the BDNF rs10835210 polymorphism on attention (FDR p = 0.006) was observed in MUD patients, but not in healthy controls. Post hoc analyses revealed that among carriers of the BDNF rs10835210 A allele, MUD patients with CM had lower RBANS attention scores (FDR p < 0.001) than those without CM. In contrast, no significant simple main effect of CM on RBANS attention was found among MUD patients carrying BDNF rs10835210 CC genotype.
conclusionsOur findings suggest that CM impairs multiple aspects of cognitive function in MUD patients. Moreover, the BDNF gene rs10835210 polymorphism mediates the effect of CM on cognitive function in this population.
Indexed as
Identifiers
40580351What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.